Two PML Deaths Confirmed in Patients Taking Raptiva

Drug Industry Daily
A A
Two patients who took Genentech’s psoriasis drug Raptiva for more than three years have died of progressive multifocal leukoencephalopathy (PML), a rare brain infection, and a third person who may have had the disease died of unknown causes.

To View This Article:

Login

Subscribe To Drug Industry Daily